U.S. Stem Cell, Inc.
USRM - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$64.15K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $64,151.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | 0.67 |
| Outstanding Shares | 591,558,288 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | 0.18 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About U.S. Stem Cell, Inc.
11 employees
CEO: Michael Tomas
U.S. Stem Cell, Inc. is a biotechnology firm dedicated to the advancement and commercialization of autologous cellular therapies throughout the United States. Its core mission is to address a range of medical conditions, including both c...